Cargando…
Optimizing and developing a scalable, chemically defined, animal component-free lentiviral vector production process in a fixed-bed bioreactor
Lentiviral vectors (LVVs) play a critical role in gene delivery for ex vivo gene-modified cell therapies. However, the lack of scalable LVV production methods and the high cost associated with them may limit their use. In this work, we demonstrate the optimization and development of a scalable, chem...
Autores principales: | Fiol, Carme Ripoll, Collignon, Marie-Laure, Welsh, John, Rafiq, Qasim A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388200/ https://www.ncbi.nlm.nih.gov/pubmed/37528866 http://dx.doi.org/10.1016/j.omtm.2023.06.011 |
Ejemplares similares
-
Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor
por: Valkama, A J, et al.
Publicado: (2018) -
Lentiviral Vector Production from a Stable Packaging Cell Line Using a Packed Bed Bioreactor
por: Powers, Alicia D., et al.
Publicado: (2020) -
Large-scale Clinical-grade Retroviral Vector Production in a Fixed-Bed Bioreactor
por: Wang, Xiuyan, et al.
Publicado: (2015) -
Lentiviral Vectors for T Cell Engineering: Clinical Applications, Bioprocessing and Future Perspectives
por: Labbé, Roman P., et al.
Publicado: (2021) -
Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production
por: Leinonen, Hanna M., et al.
Publicado: (2020)